How much does Bioscript Stirling Limited make?

Bioscript Stirling Limited reported revenue of £11.9m and £3m profit in the year to 30 Sep 2024, according to its accounts filed at Companies House.

How many employees does Bioscript Stirling Limited have?

Bioscript Stirling Limited reported an average of 98 employees in the year to 30 Sep 2024.

Is Bioscript Stirling Limited profitable?

Yes — Bioscript Stirling Limited reported a profit of £3m in the year to 30 Sep 2024.

Company No. 04354625 · Incorporated 17 Jan 2002

Bioscript Stirling Limited

Registered name: BIOSCRIPT STIRLING LIMITED

Part of Sovereign Capital Partners LLP group

Bioscript Stirling Limited made £11.9m revenue and £3m profit in the year to 30 Sep 2024.

Bioscript Stirling Limited’s revenue grew 8% to £11.9m in the year to 30 Sep 2024, with £3m profit and 98 employees. The company is classified under “management consultancy activities other than financial management” and is based in Macclesfield; we hold 3 years of its filed accounts.

Full P&L filedSection M · Professional, scientific and technical activitiesSIC 70229Management consultancy activities other than financial management

Status: Active
Location: Macclesfield, North West
Age: 24 yrs · since 2002
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 30 Sep 2024

Key figures

Capital-lightOperating leverageDoing more with less

Revenue

£11.9m

Growth ▲8.3%

Profit

£3m

Growth ▲106.6%

Profit margin

25.3%

Gross 46.6%

Employees

Change ▼2%

Profit / employee

£30.8k

Revenue/employee £122k

Profitable streak

3yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

3 filed years

Financial history

Multi-year financials, oldest to newest
Year to	30 Sep 2022	30 Sep 2023	30 Sep 2024
Disclosure	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£10.5m	£11m	£11.9m
Cost of sales	£6.5m	£6.6m	£6.4m
Gross profit	£4.1m	£4.4m	£5.6m
Operating profit	£2.1m	£1.5m	£3.1m
Profit before tax	£2.1m	£1.5m	£3.1m
Profit after tax	£1.7m	£1.5m	£3m
Profit (best available)	£1.7m	£1.5m	£3m
Staff costs	£5.3m	£5.4m	£5.4m
Employees (average)	99	100	98
Ratios
Profit margin	16.2%	13.3%	25.3%
Gross margin	38.7%	39.8%	46.6%
Revenue per employee	£106k	£110k	£122k
Profit per employee	£17.2k	£14.6k	£30.8k
Growth (year on year)
Revenue growth	—	▲4.5%	▲8.3%
Profit growth	—	▼14.5%	▲106.6%
Headcount growth	—	▲1%	▼2%
Balance sheet — indirect signals, not revenue
Cash at bank	£471k	£432k	£808k
Net assets	£4.3m	£5.8m	£8.8m
Fixed assets	£130k	£241k	£161k
Current assets	£7.1m	£10.9m	£17.8m
Debtors	£1.5m	£1.8m	£1.8m
Deferred income	£1.2m	£870k	£1.1m
Source	FullAccounts · bulk data Sep 2024	FullAccounts · bulk data Sep 2024	FullAccounts · bulk data Jun 2025

Derived from the latest filing

How the business works

Profit margin: 25.3%; Profit ÷ revenue.
Gross margin: 46.6%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £122k; Revenue ÷ average employees.
Profit per employee: £30.8k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: 1.4%; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 9.2%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 15.2%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▲52%; Now £8.8m
Cash at bank: ▲87%; Now £808k
Headcount: ▼2%; Now 98
Deferred income: ▲26%; Now £1.1m
Fixed assets: ▼33%; Now £161k

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

Sovereign Capital Partners LLPultimate parent75–100%
BB Shelf 4 LLP75–100%
Bioscript Holdings Limited75–100%
Bioscript Midco 1 Limited75–100%
Bioscript Midco 2 Limited75–100%
Bioscript Limited75–100%
Bioscript Group Limited75–100%
Bioscript Stirling Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (1)

Medologie LimitedRev. — · Profit −£429

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 30 Sep 2024 (profit £3m), from the Companies House accounts bulk data published Jun 2025. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.